Wearable Devices Implements Reverse Split to Maintain Nasdaq Listing
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 10 hours ago
0mins
Source: Newsfilter
- Reverse Split Announcement: Wearable Devices Ltd. plans a 1-for-3 reverse stock split to increase the per-share trading price and comply with Nasdaq's $1.00 minimum bid requirement, effective June 22, 2026, to protect its listing status.
- Shareholder Approval: The reverse split was approved at a special shareholder meeting on June 4, 2026, with the board confirming the split ratio, thereby mitigating the risk of immediate delisting within the next two years.
- Share Adjustment: Post-split, the company's outstanding shares will decrease from 6,568,408 to approximately 2,189,469, while publicly held warrants will drop from 32,886 to about 10,962, ensuring minimal impact on shareholder equity.
- Compliance Maintenance: This reverse split aims to proactively meet Nasdaq's regulatory requirements, ensuring the continued listing of its ordinary shares and warrants, thereby enhancing the company's stability in the capital market and boosting investor confidence.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy WLDS?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on WLDS
About WLDS
Wearable Devices Ltd is an Israel-based company. Wearable Devices Ltd is primarily engaged in developing a non-invasive neural input interface technology for business-to-business (B2B) and business-to-customer (B2C) customers. Company's products are non-invasive neural input interface closed in the form of a wristband to allow control of other digital devices with natural subtle hand finger movements and fingertip pressure. Company's technology is used in digital devices such as, consumer electronics, smart watches, smartphones, Augmented Reality (AR) glasses, Virtual Reality (VR) headsets, televisions, personal computers (PCs), laptop , drones, robots. Company's product portfolio includes Mudra Band and Mudra Inspire.
About the author

Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
- Reverse Split Announcement: Wearable Devices Ltd. plans a 1-for-3 reverse stock split to increase the per-share trading price and comply with Nasdaq's $1.00 minimum bid requirement, effective June 22, 2026, to protect its listing status.
- Shareholder Approval: The reverse split was approved at a special shareholder meeting on June 4, 2026, with the board confirming the split ratio, thereby mitigating the risk of immediate delisting within the next two years.
- Share Adjustment: Post-split, the company's outstanding shares will decrease from 6,568,408 to approximately 2,189,469, while publicly held warrants will drop from 32,886 to about 10,962, ensuring minimal impact on shareholder equity.
- Compliance Maintenance: This reverse split aims to proactively meet Nasdaq's regulatory requirements, ensuring the continued listing of its ordinary shares and warrants, thereby enhancing the company's stability in the capital market and boosting investor confidence.
See More
- Reverse Stock Split Announcement: Wearable Devices has announced a one-for-three reverse stock split aimed at increasing the per-share trading price to meet Nasdaq's minimum bid price requirement of $1.00, thereby ensuring continued listing compliance.
- Trading Symbols Unchanged: Following the reverse split, the company's ordinary shares and tradable warrants will continue to trade on Nasdaq under the existing symbols 'WLDS' and 'WLDSW', with trading on a split-adjusted basis set to begin on June 22, 2026.
- Market Reaction: Following the reverse split announcement, Wearable Devices' stock price fell 7% in premarket trading, currently priced at $0.75, indicating cautious market sentiment that may affect investor confidence.
- Compliance Pressure: The primary purpose of this reverse split is to address compliance pressures from Nasdaq; failure to meet the minimum bid price could lead to delisting risks, posing challenges to the company's long-term growth prospects.
See More
- Lucid Stock Decline: Lucid's shares fell over 7.5% on Monday, extending a five-day decline to a 52-week low of $6.75, primarily driven by financing decisions and the appointment of a new CEO, reflecting market uncertainty about the company's future.
- Financing Concerns Intensify: Last week, Lucid announced a $1.05 billion capital raise, including a $300 million registered offering of common stock; despite Uber increasing its stake in Lucid to 11.5%, analysts lowered price targets, with TD Cowen cutting it from $19 to $10 and Baird from $14 to $12.
- Aspire Biopharma Financing Issues: Aspire Biopharma's stock declined for four consecutive days, hitting a low of $0.22 on Monday after announcing the closure of a $21 million private placement and securing an additional $22.5 million credit line for acquiring Dura Control Systems, indicating significant financing pressure.
- Wearable Devices Stock Drop: Wearable Devices' shares fell to $1.10 on Monday after entering a $5 million warrant inducement agreement, intended for working capital; however, the company failed to alleviate investor concerns regarding dilution and funding needs.
See More
- Financing Agreement Reached: Wearable Devices has entered into a warrant inducement agreement with an existing institutional investor for the immediate exercise of 2,904,499 existing warrants at an exercise price of $1.73 per share, expected to raise approximately $5 million in cash, enhancing the company's working capital and operational capacity.
- New Warrants Issued: As part of the transaction, the investor will receive 5,082,873 new warrants with an exercise price of $1.51 per share, which are immediately exercisable and will expire in five years, further improving the company's capital structure and financing flexibility.
- Transaction Timeline: The warrant inducement transaction is expected to close on April 21, 2026, subject to customary closing conditions, demonstrating the company's activity in the capital markets and confidence in future growth.
- Market Compliance: This transaction relies on an exemption under Section 4(a)(2) of the Securities Act of 1933, ensuring compliance for the newly issued securities in the U.S. market, reflecting the company's commitment to legal regulations and its compliant operations in the capital markets.
See More
- Clear Partnership Goals: Wearable Devices' collaboration with Meta-Bounds aims to integrate its Mudra Band and Mudra Link products for spatial interaction, focusing on end consumers in the short term and enterprise users in the long term, demonstrating the company's deep understanding of market demands.
- Significant Stock Surge: Following the announcement of the partnership with Meta-Bounds, Wearable Devices' shares surged nearly 115% on Monday, marking the best intraday gain in over seven months, reflecting strong market optimism regarding its AR control technology.
- Product Development Plans: In the short term, Wearable Devices plans to develop preliminary wristband controllers that allow users to control their AR experience through gestures, enhancing user interaction and promoting the adoption of AR technology.
- Expansive Market Outlook: According to a report by Fortune Business Insights, the global AR market is projected to grow to $2.3 trillion by 2034, positioning Wearable Devices strategically to capitalize on this rapidly expanding market.
See More
- Financial Highlights: Wearable Devices reported a GAAP EPS of -$6.53 for FY 2025 with revenues of $0.65 million, indicating significant challenges in profitability that could impact investor confidence.
- Cash Position: As of December 31, 2025, the company reported cash and deposits of $18.4 million, a substantial increase from $4.0 million at the end of 2024, primarily due to approximately $24.4 million raised in 2025, enhancing financial stability.
- Sales and Marketing Expenses: Sales and marketing expenses decreased by 12% to $1.85 million for FY 2025, reflecting adjustments in the sales and marketing structure, although overall spending still needs attention to enhance market competitiveness.
- Stable Administrative Costs: General and administrative expenses remained steady at $2.8 million for FY 2025, unchanged from FY 2024, indicating efforts to control management costs, but further optimization is necessary to improve overall profitability.
See More








